Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379919 · ClinicalTrials.gov registry record · NA
Wound Irrigation Comparative Effectiveness Study
A NA study of Cutibacterium Acnes Contamination, sponsored by Orthopaedic Education and Research Institute (dba Hoag Orthopedics).
- Recruiting
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT06379919: Recruiting NA study of Cutibacterium Acnes Contamination, sponsored by Orthopaedic Education and Research Institute (dba Hoag Orthopedics).
NCT06379919 is a NA study of Cutibacterium Acnes Contamination that is actively recruiting participants, run by Orthopaedic Education and Research Institute (dba Hoag Orthopedics). The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06379919, a NA study of Cutibacterium Acnes Contamination, is actively recruiting participants, sponsored by Orthopaedic Education and Research Institute (dba Hoag Orthopedics).
- RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the presence of C acnes in bacteriologic cultures taken from participant samples of subcutaneous and deep tissue prior to deep surgical irrigation using either Normal Saline Irrigation (Group 1) or Irrisept Irrigation (Group 2). Secondary objectives are evaluation of patient reported outcome measures and range of motion in relation to C acnes presence among subjects in the two groups.
Primary Outcome
The primary outcome of this study is to compare the presence of C acnes in bacteriologic cultures taken from participant samples of subcutaneous and deep tissue prior to deep surgical irrigation using either Normal Saline Irrigation (Group 1) or Irrisept Irrigation (Group 2)rimary objecti
Conditions Studied
Interventions
- PROCEDURE Irrisept Irrigation
- PROCEDURE Saline Irrigation Solution Delivery
Study Locations (1)
California
- Hoag Orthopedics - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What NCT06379919 shows while recruiting
NCT06379919 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cutibacterium Acnes Contamination appearing as the primary indexed condition, and to 2 interventions - of which Irrisept Irrigation is the first listed.
NCT06379919 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06379919 about?
NCT06379919 is a clinical study titled "Wound Irrigation Comparative Effectiveness Study". The primary objective of this study is to compare the presence of C acnes in bacteriologic cultures taken from participant samples of subcutaneous and deep tissue prior to deep surgical irrigation using either Normal Saline Irrigation (Group 1) or Irrisept Irrigation (Group 2). Secondary objectives ...
What is the current status of trial NCT06379919?
This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-03-20. Estimated completion is 2027-05-31.
What conditions does trial NCT06379919 study?
This clinical trial studies the following conditions: Cutibacterium Acnes Contamination.
What interventions are being tested in trial NCT06379919?
The interventions under investigation include: Irrisept Irrigation (PROCEDURE), Saline Irrigation Solution Delivery (PROCEDURE).
Who is sponsoring clinical trial NCT06379919?
This trial is sponsored by Orthopaedic Education and Research Institute (dba Hoag Orthopedics), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06379919 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06379919's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI